MedPath

Health related quality of life after radical cystectomy

Not Applicable
Conditions
Bladder cancer treated with radical cystectomy
Cancer
Bladder (urinary) cancer
Registration Number
ISRCTN99427820
Lead Sponsor
Inst Translational Medicine, Lund University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Ongoing
Sex
All
Target Recruitment
900
Inclusion Criteria

Patients with bladder cancer scheduled to have a radical cystectomy

Exclusion Criteria

Does not give consent

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
HRQoL at 12 months after radical cystectomy for bladder cancer, assessed with tFACT-G and FACT-VCI.
Secondary Outcome Measures
NameTimeMethod
The secondary outcome measures are the HRQoL items functional wellbeing, social wellbeing, emotional wellbeing and physical wellbeing. These are measured 12 months after surgery. The method used is the FACT-VCI questionnaire, as for the primary outcome measures.
© Copyright 2025. All Rights Reserved by MedPath